Folic acid antagonists can be divided into two groups: (a) DHFR inhibitors (eg, sulfamethoxazole-trimethoprim), which block the conversion of folate to its more active metabolites (Figure 1), and (b) other folic acid antagonists, a group consisting primarily of anticonvulsant medications (phenobarbital, phenytoin, primidone, and carbamazepine) but also including Spasmophen (an antispasmodic drug that contains low doses of phenobarbital) and cholestyramine
The Peptide Calculator and every product listed are supplied strictly for in-vitro laboratory and research use within Australia
Time to focus on validated, proven ingredients that deliver real support, not just regulatory confusion
***14-DAY MONEY-BACK GUARANTEE
Market and Quality Risks Grey market and compounded peptide products can suffer from variable potency, contamination, or mislabeling, and FDA warning actions illustrate enforcement against vendors marketing unapproved BPC157 formulations
Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene